|
|
|
|
| LEADER |
03188nam a2200685 4500 |
| 001 |
ocn836557855 |
| 003 |
OCoLC |
| 005 |
20170124070724.9 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
130405s2013 enk ob 001 0 eng |
| 010 |
|
|
|a 2013014058
|
| 040 |
|
|
|a DLC
|b eng
|e rda
|c DLC
|d YDX
|d N$T
|d DG1
|d IDEBK
|d CUS
|d YDXCP
|d NOC
|d CDX
|d COO
|d RIV
|d CNMTR
|d EBLCP
|d GrThAP
|
| 019 |
|
|
|a 889930243
|
| 020 |
|
|
|a 9781118610732 (ePub)
|
| 020 |
|
|
|a 1118610733 (ePub)
|
| 020 |
|
|
|a 9781118610756 (Adobe PDF)
|
| 020 |
|
|
|a 111861075X (Adobe PDF)
|
| 020 |
|
|
|a 9781118610763 ( MobiPocket)
|
| 020 |
|
|
|a 1118610768 ( MobiPocket)
|
| 020 |
|
|
|z 9781119976868 (hardback)
|
| 020 |
|
|
|a 9781118610749
|
| 020 |
|
|
|a 1118610741
|
| 020 |
|
|
|a 9781299465282
|
| 020 |
|
|
|a 1299465285
|
| 020 |
|
|
|z 1119976863
|
| 029 |
1 |
|
|a AU@
|b 000050743026
|
| 029 |
1 |
|
|a CHBIS
|b 010026886
|
| 029 |
1 |
|
|a CHVBK
|b 306230526
|
| 029 |
1 |
|
|a NZ1
|b 15340526
|
| 029 |
1 |
|
|a DEBBG
|b BV043395716
|
| 035 |
|
|
|a (OCoLC)836557855
|z (OCoLC)889930243
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a RM666.R554
|
| 072 |
|
7 |
|a SCI
|x 049000
|2 bisacsh
|
| 082 |
0 |
0 |
|a 572.8/8
|2 23
|
| 084 |
|
|
|a SCI013040
|2 bisacsh
|
| 049 |
|
|
|a MAIN
|
| 245 |
0 |
0 |
|a Advanced delivery and therapeutic applications of RNAi /
|c edited by Kun Cheng and Ram I. Mahato.
|
| 264 |
|
1 |
|a Chichester, West Sussex :
|b Wiley,
|c [2013]
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|2 rdacontent
|
| 337 |
|
|
|a computer
|2 rdamedia
|
| 338 |
|
|
|a online resource
|2 rdacarrier
|
| 520 |
|
|
|a "Commonly used by researchers to develop technologies for modifying and studying genetic process, RNA interference (RNAi) has many potential uses in medicine, biotechnology, and functional genomics. This book covers all essential aspects involved in the development of RNAi therapeutics, providing detailed guidance on the challenges and opportunities of bringing RNAi technologies from bench to clinic. It explores the design and mechanism of RNAi molecules, delivery strategies, and therapeutic applications in various diseases. Preclinical, regulatory, market, and intellectual aspects of RNAi technologies are also covered"--
|c Provided by publisher.
|
| 520 |
|
|
|a "All of the essential aspects of developing RNAi therapeutics from bench to clinic presented in a single volume"--
|c Provided by publisher.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
|
|
|a Description based on print version record and CIP data provided by publisher.
|
| 650 |
|
0 |
|a RNA
|x Therapeutic use.
|
| 650 |
|
0 |
|a Small interfering RNA
|x Therapeutic use.
|
| 650 |
|
7 |
|a SCIENCE / Chemistry / Organic
|2 bisacsh
|
| 650 |
|
2 |
|a RNA Interference.
|
| 650 |
|
2 |
|a RNA, Small Interfering
|x therapeutic use.
|
| 650 |
|
7 |
|a RNA
|x Ús terapèutic.
|2 lemac
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Cheng, Kun,
|e editor of compilation.
|
| 700 |
1 |
|
|a Mahato, Ram I.,
|e editor of compilation.
|
| 776 |
0 |
8 |
|i Print version:
|t Advanced delivery and therapeutic applications of RNAi
|d Chichester, West Sussex : John Wiley & Sons Inc. [2013]
|z 9781119976868
|w (DLC) 2013012774
|
| 856 |
4 |
0 |
|u https://doi.org/10.1002/9781118610749
|z Full Text via HEAL-Link
|
| 994 |
|
|
|a 92
|b DG1
|
